Mantle Cell Lymphoma (MCL) Terminated Phase 2 Trials for Rituximab (DB00073)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01497275Zevalin and Velcade in Relapsed/Refractory Mantle Cell LymphomaTreatment
NCT00183989Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell LymphomaTreatment